SearchPublisher and Institutes
Sitemap
Medical science
02/2005 A novel device for the non – invasive measurement of free hemoglobin in blood bags / 02/2005 Lösungsansätze für haptische Assistenz bei Katheterisierungen / 02/2005 Cutaneous Microcirculation is not altered by a Weak 50 Hz Magnetic Field / 02/2005 Semiautomatisches Verfahren für die Untersuchung des synchronen Verhaltens von EEG- und Herzraten-Mustern bei Frühgeborenen / 02/2005 Characterization of mode II – wear particles and cytokine response in a human macrophage – like cell culture / 02/2005 Cementless Vektor-Titan stem in total hip arthroplasty / 03/2005 Effects of human cytomegalovirus infection on the coagulation system 03/2005 Protein Z and protein Z-dependent protease inhibitor. Determinants of levels and risk of venous thrombosis 03/2005 Molecular mechanism of dysfunctional factor VII associated with the homozygous missense mutation 331Gly to Ser 03/2005 Gene duplication of coagulation factor V and origin of venom prothrombin activator in Pseudonaja textilis snake 03/2005 Improvement of the specificity of dipetarudin by site directed mutagenesis 03/2005 Antithrombotic potential of new direct thrombin inhibitors built on the azaphenylalanine scaffold in two rat venous thrombosis models 03/2005 Complement activation: the missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathies 03/2005 The factor VIII D1241E polymorphism is associated with decreased factor VIII activity and not with activated protein C resistance levels 03/2005 Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A. Results of an international clinical investigation 03/2005 The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism 03/2005 Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B 03/2005 Clinical phenotypes and factor VII genotype in congenital factor VII deficiency 03/2005 Risk factors associated with symptomatic pulmonary embolism in a large cohort of deep vein thrombosis patients 03/2005 Post-thrombotic syndrome, functional disability and quality of life after upper extremity deep venous thrombosis in adults 03/2005 Performance of magnetic resonance angiography in suspected acute pulmonary embolism 03/2005 Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension 03/2005 High glucose rapidly activates the nitric oxide/cyclic nucleotide pathway in human platelets via an osmotic mechanism 03/2005 Effects of aspirin, clopidogrel and dipyridamole administered singly and in combination on platelet and leucocyte function in normal volunteers and patients with prior ischaemic stroke 03/2005 Nitroaspirin plus clopidogrel versus aspirin plus clopidogrel against platelet thromboembolism and intimal thickening in mice 03/2005 Variability in clinical laboratory practice in testing for disorders of platelet function: Results of two surveys of the North American Specialized Coagulation Laboratory Association 03/2005 Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation 03/2005 Adhesion molecules and cardiovascular risk in peripheral arterial disease. Soluble vascular cell adhesion molecule-1 improves risk stratification 03/2005 455 G/A polymorphism and preprocedural plasma levels of fibrinogen show no association with the risk of clinical restenosis in patients with coronary stent placement 03/2005 Contribution of haplotypes across the fibrinogen gene cluster to variation in risk of myocardial infarction 03/2005 The alkylating carcinogen N-methyl-N-nitro-N-nitrosoguanidine activates the plasminogen activator inhibitor-1 gene through sequential phosphorylation of p53 by ATM and ATR kinases 03/2005 Cost-effectiveness of low-molecular-weight heparin for secondary prophylaxis of cancer-related venous thromboembolism 03/2005 ProC Global: A functional screening test that predicts recurrent venous thromboembolism 03/2005 Effect of age on the performance of a diagnostic strategy based on clinical probability, spiral computed tomography and venous compression ultrasonography. The ESSEP study 03/2005 Effect of stress doses of hydrocortisone on S-100B vs. interleukin-8 and polymorphonuclear elastase levels in human septic shock 03/2005 Conjugated linoleic acid suppresses the secretion of atherogenic lipoproteins from human HepG2 liver cells 03/2005 Determination of debrisoquine and 4-hydroxydebrisoquine by high-performance liquid chromatography: application to the evaluation of
03/2005 Assessment of iodine intake in mildly iodine-deficient pregnant women by a new automated kinetic urinary iodine determination method 03/2005 Butyrylcholinesterase activity and metabolic syndrome in obese patients 03/2005 The non-thyroidal illness syndrome after coronary artery bypass grafting: a 6-month follow-up study 03/2005 Advanced oxidation protein products (AOPP) for monitoring oxidative stress in critically ill patients: a simple, fast and inexpensive automated technique 03/2005 Quality control in urinary stone analysis: results of 44 ring trials (1980–2001) 03/2005 External Quality Assessment in The Netherlands: time to introduce commutable survey specimens. Lessons from the Dutch “Calibration 2000” project 03/2005 Evaluation of a high-sensitivity turbidimetric immunoassay for serum C-reactive protein: application to the study of longitudinal changes throughout normal pregnancy 03/2005 A quantitative appraisal of interference by icodextrin metabolites in point-of-care glucose analyses 03/2005 Preanalytical variability in laboratory testing: influence of the blood drawing technique 03/2005 Soluble transferrin receptor and transferrin receptor-ferritin index in iron deficiency anemia and anemia in rheumatoid arthritis 03/2005 Elevated plasma cysteinylglycine levels caused by cilastatin-associated antibiotic treatment 03/2005 The number of consultant clinical chemists in the 15-nation European Union 03/2005 Maternal obesity and complications during pregnancy 03/2005 Cesarean section upon request: is it appropriate for everybody? 03/2005 Characteristics of mothers who delivered the heaviest, average-weight, and lightest triplet sets 03/2005 Gestational age-specific distribution of twin birth weight discordance 03/2005 The comparison of amino-terminal probrain natriuretic peptide levels in preeclampsia and normotensive pregnancy 03/2005 Optimal timing for postprandial glucose measurement in pregnant women with diabetes and a non-diabetic pregnant population evaluated by the Continuous Glucose Monitoring System (CGMS®) 03/2005 Structural-tridimensional study of yolk sac in pregnancies complicated by diabetes 03/2005 Is cervical dilatation during parturition at term associated with apoptosis? 03/2005 Increased soluble VCAM-1 serum levels in preeclampsia are not correlated to urinary excretion or circadian blood pressure rhythm 03/2005 The association of birthweight with maternal and cord serum and amniotic fluid growth hormone and insulin levels, and with neonatal and maternal factors in pregnant women who delivered at term 03/2005 Amniotic fluid lamellar body counts for the determination of fetal lung maturity: an update 03/2005 Comparison of clinical criteria with echocardiographic findings in diagnosing PDA in preterm infants 03/2005 Sudden infant death syndrome “gray zone” disclosed only by a study of the brain stem on serial sections 03/2005 Incidence and diagnosis of unilateral arterial cerebral infarction in newborn infants 03/2005 Non-hydropic intrauterine fetal death more than 5 months after primary parvovirus B19 infection 03/2005 A new syndrome of myopathy with muscle spindle excess* 04/2005 Thrombolytic agents 04/2005 Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease 04/2005 The urokinase receptor and the regulation of cell proliferation 04/2005 Structure and function of the plasminogen/plasmin system 04/2005 Tissue plasminogen activator in central nervous system physiology and pathology Back